These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30932802)

  • 1. Hospital epidemiologists' and infection preventionists' opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric.
    Dantes RB; Abbo LM; Anderson D; Hall L; Han JH; Harris AD; Leekha S; Milstone AM; Morgan DJ; Safdar N; Schweizer ML; Sengupta S; Seo SK; Rock C
    Infect Control Hosp Epidemiol; 2019 May; 40(5):536-540. PubMed ID: 30932802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and preventability of hospital-onset bacteremia and fungemia in 2 hospitals in India.
    Gandra S; Singh SK; Chakravarthy M; Moni M; Dhekane P; Mohamed Z; Shameen F; Vasudevan AK; Senthil P; Saravanan T; George A; Sinclair D; Stwalley D; van Rheenen J; Westercamp M; Smith RM; Leekha S; Warren DK
    Infect Control Hosp Epidemiol; 2024 Feb; 45(2):157-166. PubMed ID: 37593953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study.
    Leekha S; Robinson GL; Jacob JT; Fridkin S; Shane A; Sick-Samuels A; Milstone AM; Nair R; Perencevich E; Puig-Asensio M; Kobayashi T; Mayer J; Lewis J; Bleasdale S; Wenzler E; Mena Lora AJ; Baghdadi J; Schrank GM; Wilber E; Aldredge AA; Sharp J; Dyer KE; Kendrick L; Ambalam V; Borgetti S; Carmack A; Gushiken A; Patel A; Reddy S; Brown CH; Dantes RB; Harris AD;
    BMJ Qual Saf; 2024 Jul; 33(8):487-498. PubMed ID: 38782579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.
    Yu KC; Jung M; Ai C
    Infect Control Hosp Epidemiol; 2023 Dec; 44(12):1920-1926. PubMed ID: 37424226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology and utility of hospital-onset bacteremia as a safety metric for targeted harm reduction.
    Stack MA; Dbeibo L; Fadel W; Kelley K; Sadowski J; Beeler C
    Am J Infect Control; 2024 Feb; 52(2):195-199. PubMed ID: 37295676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure.
    Dantes RB; Rock C; Milstone AM; Jacob JT; Chernetsky-Tejedor S; Harris AD; Leekha S
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):358-361. PubMed ID: 30773166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Experts Understand Performance Measures? A Mixed-Methods Study of Infection Preventionists.
    Govindan S; Wallace B; Iwashyna TJ; Chopra V
    Infect Control Hosp Epidemiol; 2018 Jan; 39(1):71-76. PubMed ID: 29202884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicenter Longitudinal Study of Hospital-Onset Bacteremia: Time for a New Quality Outcome Measure?
    Rock C; Thom KA; Harris AD; Li S; Morgan D; Milstone AM; Caffo B; Joshi M; Leekha S
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):143-8. PubMed ID: 26493213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals.
    Yu KC; Ye G; Edwards JR; Gupta V; Benin AL; Ai C; Dantes R
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1317-1325. PubMed ID: 36082774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a structured guide to assess the preventability of hospital-onset bacteremia and fungemia.
    Schrank GM; Sick-Samuels A; Bleasdale SC; Jacob JT; Dantes R; Gokhale RH; Mayer J; Mehrotra P; Mehta SA; Mena Lora AJ; Ray SM; Rhee C; Salinas JL; Seo SK; Shane AL; Nadimpalli G; Milstone AM; Robinson G; Brown CH; Harris AD; Leekha S;
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1326-1332. PubMed ID: 35086601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-onset bacteremia and fungemia: examining healthcare-associated infections prevention through a wider lens.
    Schrank GM; Snyder GM; Leekha S
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e198. PubMed ID: 38028924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing and reporting of central line-associated bloodstream infections.
    Beekmann SE; Diekema DJ; Huskins WC; Herwaldt L; Boyce JM; Sherertz RJ; Polgreen PM;
    Infect Control Hosp Epidemiol; 2012 Sep; 33(9):875-82. PubMed ID: 22869260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition.
    See I; Iwamoto M; Allen-Bridson K; Horan T; Magill SS; Thompson ND
    Infect Control Hosp Epidemiol; 2013 Aug; 34(8):769-76. PubMed ID: 23838215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.
    Oh JY; Cunningham MC; Beldavs ZG; Tujo J; Moore SW; Thomas AR; Cieslak PR
    Infect Control Hosp Epidemiol; 2012 May; 33(5):439-45. PubMed ID: 22476268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
    Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
    Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of central line-associated bloodstream infections: a survey of ICU nurses' knowledge and practice in China.
    Chi X; Guo J; Niu X; He R; Wu L; Xu H
    Antimicrob Resist Infect Control; 2020 Nov; 9(1):186. PubMed ID: 33198796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients.
    Metzger KE; Rucker Y; Callaghan M; Churchill M; Jovanovic BD; Zembower TR; Bolon MK
    Infect Control Hosp Epidemiol; 2015 Feb; 36(2):119-24. PubMed ID: 25632993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
    Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Vascular Access Device-Associated Hospital Onset Bacteremia and Fungemia: A Review of Emerging Perspectives and Synthesis of Technical Aspects.
    Garcia R; Septimus EJ; LeDonne J; Sturm LK; Moureau N; DeVries M; DeBaun B
    Clin Infect Dis; 2024 May; ():. PubMed ID: 38709254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital-onset bacteremia: clinical and regulatory ramifications.
    Yu KC; Patkar A
    Future Microbiol; 2023 Nov; 18():1133-1136. PubMed ID: 37902608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.